The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Clearance of persistent HPV infection and cervical lesion by therapeutic DNA vaccine in CIN3 patients
Open accessAbstract
Here, we demonstrate that electroporation-enhanced immunization with a rationally designed HPV DNA vaccine (GX-188E), preferentially targeting HPV antigens to dendritic cells, elicits a significant E6/E7-specific IFN-γ-producing T-cell response in all nine cervical intraepithelial neoplasia 3 (CIN3) patients. Importantly, eight out of nine patients exhibit an enhanced polyfunctional HPV-specific CD8 T-cell response as shown by an increase in cytolytic activity, proliferative capacity and secretion of effector molecules. Notably, seven out of nine patients display complete regression of their lesions and viral clearance within 36 weeks of follow up. GX-188E administration does not elicit serious vaccine-associated adverse events at all administered doses. These findings indicate that the magnitude of systemic polyfunctional CD8 T-cell response is the main contributing factor for histological, cytological and virological responses, providing valuable insights into the design of therapeutic vaccines for effectively treating persistent infections and cancers in humans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gerdes, J., Lemke, H., Baisch, H., Wacker, H. H., Schwab, U., & Stein, H. (1984) · The Journal of Immunology · doi:10.4049/jimmunol.133.4.1710 · Cited by 4,173
Human papillomavirus and cervical cancer
Schiffman, M., Castle, P. E., Jeronimo, J., Rodriguez, A. C., & Wacholder, S. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61416-0 · Cited by 2,985
Effector and memory T-cell differentiation: implications for vaccine development
Kaech, S. M., Wherry, E. J., & Ahmed, R. (2002) · Nature Reviews Immunology · doi:10.1038/nri778 · Cited by 1,865
Global Burden of Human Papillomavirus and Related Diseases
Forman, D., de Martel, C., Lacey, C. J., Soerjomataram, I., Lortet-Tieulent, J., Bruni, L., Vignat, J., Ferlay, J., Bray, F., Plummer, M., et al. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.07.055 · Cited by 1,642
Wherry, E. J., Blattman, J. N., Murali-Krishna, K., van der Most, R., & Ahmed, R. (2003) · Journal of Virology · doi:10.1128/jvi.77.8.4911-4927.2003 · Cited by 1,610
Betts, M. R., Brenchley, J. M., Price, D. A., De Rosa, S. C., Douek, D. C., Roederer, M., & Koup, R. A. (2003) · Journal of Immunological Methods · doi:10.1016/s0022-1759(03)00265-5 · Cited by 1,587
Chapter 2: The burden of HPV-related cancers
Parkin, D. M., & Bray, F. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.05.111 · Cited by 1,385
Kyrgiou, M., Koliopoulos, G., Martin-Hirsch, P., Arbyn, M., Prendiville, W., & Paraskevaidis, E. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68181-6 · Cited by 1,120
Vaccination against HPV-16 Oncoproteins for Vulvar Intraepithelial Neoplasia
Kenter, G. G., Welters, M. J. P., Valentijn, A. R. P. M., Lowik, M. J. G., Berends-van der Meer, D. M. A., Vloon, A. P. G., Essahsah, F., Fathers, L. M., Offringa, R., Drijfhout, J. W., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810097 · Cited by 1,102
Distinct dendritic cell subsets differentially regulate the class of immune response invivo
Pulendran, B., Smith, J. L., Caspary, G., Brasel, K., Pettit, D., Maraskovsky, E., & Maliszewski, C. R. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.3.1036 · Cited by 991
Memory CD8 T-Cell Differentiation during Viral Infection
Wherry, E. J., & Ahmed, R. (2004) · Journal of Virology · doi:10.1128/jvi.78.11.5535-5545.2004 · Cited by 868
SPICE: Exploration and analysis of post‐cytometric complex multivariate datasets
Roederer, M., Nozzi, J. L., & Nason, M. C. (2011) · Cytometry Part A · doi:10.1002/cyto.a.21015 · Cited by 831
Natural History of Dysplasia of the Uterine Cervix
Holowaty, P., Miller, A. B., Rohan, T., & To, T. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.3.252 · Cited by 608
Updating the Natural History of Human Papillomavirus and Anogenital Cancers
Moscicki, A.-B., Schiffman, M., Burchell, A., Albero, G., Giuliano, A. R., Goodman, M. T., Kjaer, S. K., & Palefsky, J. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.05.089 · Cited by 413
In vivo generation of human dendritic cell subsets by Flt3 ligand
Maraskovsky, E., Daro, E., Roux, E., Teepe, M., Maliszewski, C. R., Hoek, J., Caron, D., Lebsack, M. E., & McKenna, H. J. (2000) · Blood · doi:10.1182/blood.v96.3.878 · Cited by 407
Novel Adenovirus-Based Vaccines Induce Broad and Sustained T Cell Responses to HCV in Man
Barnes, E., Folgori, A., Capone, S., Swadling, L., Aston, S., Kurioka, A., Meyer, J., Huddart, R., Smith, K., Townsend, R., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003155 · Cited by 405
Welters, M. J. P., Kenter, G. G., Piersma, S. J., Vloon, A. P. G., Löwik, M. J. G., Berends-van der Meer, D. M. A., Drijfhout, J. W., Valentijn, A. R. P. M., Wafelman, A. R., Oostendorp, J., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1880 · Cited by 373
Technologies for enhanced efficacy of DNA vaccines
Saade, F., & Petrovsky, N. (2012) · Expert Review of Vaccines · doi:10.1586/erv.11.188 · Cited by 309
Immunotherapy Against HPV16/18 Generates Potent T H 1 and Cytotoxic Cellular Immune Responses
Bagarazzi, M. L., Yan, J., Morrow, M. P., Shen, X., Parker, R. L., Lee, J. C., Giffear, M., Pankhong, P., Khan, A. S., Broderick, K. E., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004414 · Cited by 282
Clerici, M., Ferrario, E., Trabattoni, D., Villa, M. L., Clerici, E., Merola, M., Stefanon, B., De Palo, G., Venzon, D. J., & Shearer, G. M. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.3.245 · Cited by 257
Maldonado, L., Teague, J. E., Morrow, M. P., Jotova, I., Wu, T. C., Wang, C., Desmarais, C., Boyer, J. D., Tycko, B., Robins, H. S., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007323 · Cited by 255
Le, T. P., Coonan, K. M., Hedstrom, R. C., Charoenvit, Y., Sedegah, M., Epstein, J. E., Kumar, S., Wang, R., Doolan, D. L., Maguire, J. D., et al. (2000) · Vaccine · doi:10.1016/s0264-410x(99)00407-7 · Cited by 243
Systematic Review and Metaanalysis
Shimada, T., Noguchi, Y., Jackson, J. L., Miyashita, J., Hayashino, Y., Kamiya, T., Yamazaki, S., Matsumura, T., & Fukuhara, S. (2009) · Chest · doi:10.1378/chest.08-2602 · Cited by 236
Liu, X., Clements, A., Zhao, K., & Marmorstein, R. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m508455200 · Cited by 234
Yugawa, T., & Kiyono, T. (2009) · Reviews in Medical Virology · doi:10.1002/rmv.605 · Cited by 233
Clinician's guide to human papillomavirus immunology: knowns and unknowns
Einstein, M. H., Schiller, J. T., Viscidi, R. P., Strickler, H. D., Coursaget, P., Tan, T., Halsey, N., & Jenkins, D. (2009) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70108-2 · Cited by 226
Trimble, C. L., Peng, S., Kos, F., Gravitt, P., Viscidi, R., Sugar, E., Pardoll, D., & Wu, T. C. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1725 · Cited by 209
Kalams, S. A., Parker, S. D., Elizaga, M., Metch, B., Edupuganti, S., Hural, J., De Rosa, S., Carter, D. K., Rybczyk, K., Frank, I., et al. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit236 · Cited by 196
FRAZER, I., QUINN, M., NICKLIN, J., TAN, J., PERRIN, L., NG, P., OCONNOR, V, WHITE, O., WENDT, N., & MARTIN, J. (2004) · Vaccine · doi:10.1016/j.vaccine.2004.05.013 · Cited by 176
Guermonprez, P., Helft, J., Claser, C., Deroubaix, S., Karanje, H., Gazumyan, A., Darasse-Jèze, G., Telerman, S. B., Breton, G., Schreiber, H. A., et al. (2013) · Nature Medicine · doi:10.1038/nm.3197 · Cited by 167
Regression of high-grade cervical intraepithelial neoplasia with TG4001 targeted immunotherapy
Brun, J.-L., Dalstein, V., Lévêque, J., Mathevet, P., Raulic, P., Baldauf, J., Scholl, S., Huynh, B., Douvier, S., Riethmuller, D., et al. (2011) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2010.09.020 · Cited by 145
Heterologous T cell immunity in severe hepatitis C virus infection
Urbani, S., Amadei, B., Fisicaro, P., Pilli, M., Missale, G., Bertoletti, A., & Ferrari, C. I. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041058 · Cited by 138
Evolving immunosuppressive microenvironment during human cervical carcinogenesis
Kobayashi, A., Weinberg, V, Darragh, T., & Smith-McCune, K. (2008) · Mucosal Immunology · doi:10.1038/mi.2008.33 · Cited by 136
Sandoval‐Montes, C., & Santos‐Argumedo, L. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0404262 · Cited by 126
Zanier, K., ould M'hamed ould Sidi, A., Boulade-Ladame, C., Rybin, V., Chappelle, A., Atkinson, A., Kieffer, B., & Travé, G. (2012) · Structure · doi:10.1016/j.str.2012.02.001 · Cited by 125
Woo, Y. L., van den Hende, M., Sterling, J. C., Coleman, N., Crawford, R., Kwappenberg, K. M. C., Stanley, M., & van der Burg, S. H. (2009) · International Journal of Cancer · doi:10.1002/ijc.24804 · Cited by 117
Wherry, E. J., Blattman, J. N., & Ahmed, R. (2005) · Journal of Virology · doi:10.1128/jvi.79.14.8960-8968.2005 · Cited by 113
Yang, S.-H., Lee, C.-G., Park, S.-H., Im, S.-J., Kim, Y.-M., Son, J.-M., Wang, J.-S., Yoon, S.-K., Song, M.-K., Ambrozaitis, A., et al. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302751 · Cited by 111
Self-citationHPV Infection: Immunological Aspects and Their Utility in Future Therapy
Deligeoroglou, E., Giannouli, A., Athanasopoulos, N., Karountzos, V., Vatopoulou, A., Dimopoulos, K., & Creatsas, G. (2013) · Infectious Diseases in Obstetrics and Gynecology · doi:10.1155/2013/540850 · Cited by 109
Hung, C., Hsu, K., Cheng, W., Chai, C., He, L., Ling, M. F., & Wu, T. ‐. (2001) · PubMed · Cited by 106
Electroporation-based DNA immunisation: translation to the clinic
Luxembourg, A. T., Evans, C. F., & Hannaman, D. (2007) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.7.11.1647 · Cited by 102
Local cytokine profiles of patients with cervical intraepithelial and invasive neoplasia
Peghini, B. C., Abdalla, D. R., Barcelos, A. C. M., Teodoro, L. G. V. L., Murta, E. F. C., & Michelin, M. A. (2012) · Human Immunology · doi:10.1016/j.humimm.2012.06.003 · Cited by 88
Li, Z.-K., Nie, J.-J., Li, J., & Zhuang, H. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.06.108 · Cited by 74
Keefe, K. A., Schell, M. J., Brewer, C., McHale, M., Brewster, W. B., Chapman, J. A., Rose, G. S., McMeeken, D. S., Lagerberg, W., Peng, Y. M., et al. (2001) · PubMed · Cited by 63
Hahn, H. S., Kee, M., Kim, H. J., Kim, M. Y., Kang, Y. S., Park, J. S., & Kim, T. J. (2013) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2013.02.024 · Cited by 58
Self-citationSeo, S. H., Jin, H., Park, S. H., Youn, J. I., & Sung, Y. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.07.033 · Cited by 56
Self-citationNaturally occurring systemic immune responses to HPV antigens do not predict regression of CIN2/3
Trimble, C. L., Peng, S., Thoburn, C. J., Kos, F. J., & Wu, T. ‐. (2009) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-009-0806-4 · Cited by 52
van Steenwijk, P. J. D. V., Piersma, S. J., Welters, M. J. P., van der Hulst, J. M., Fleuren, G. J., Hellebrekers, B. W. J., Kenter, G. G., & van der Burg, S. H. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0994 · Cited by 42
Harper, D. M. (2009) · Public Health Genomics · doi:10.1159/000214922 · Cited by 34
Park, K. S., Seo, Y. B., Lee, J. Y., Im, S. J., Seo, S. H., Song, M. S., Choi, Y. K., & Sung, Y. C. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.05.062 · Cited by 33
Self-citationEvans, J., & Ivaldi, G. (2013) · Palgrave Macmillan eBooks · doi:10.1057/9781137011640.0005 · Cited by 29
Baden, L. R., Blattner, W. A., Morgan, C. A., Huang, Y., Defawe, O., Sobieszczyk, M. E., Kochar, N. K., Tomaras, G. D., McElrath, M. J., Russell, N. D., et al. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir615 · Cited by 27
The use of Flt3 ligand as an adjuvant for hepatitis B vaccination of healthy adults
Evans, T. G., Hasan, M. S., Galibert, L., & Caron, D. A. (2002) · Vaccine · doi:10.1016/s0264-410x(02)00454-1 · Cited by 21
Valaperti, A., Nishii, M., Germano, D., Liu, P. P., & Eriksson, U. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.07.084 · Cited by 15
Dendritic cells in models of tumor immunity. Role of Flt3 ligand
Maliszewski, C. R. (2001) · Pathologie Biologie · doi:10.1016/s0369-8114(01)00172-9 · Cited by 13
Cited by
Saxena, M., van der Burg, S. H., Melief, C. J. M., & Bhardwaj, N. (2021) · Nature reviews. Cancer · doi:10.1038/s41568-021-00346-0 · Cited by 1,581
Melief, C. J. M., van Hall, T., Arens, R., Ossendorp, F., & van der Burg, S. H. (2015) · Journal of Clinical Investigation · doi:10.1172/jci80009 · Cited by 1,164
Cancer vaccines: the next immunotherapy frontier
Lin, M. J., Svensson-Arvelund, J., Lubitz, G. S., Marabelle, A., Melero, I., Brown, B. D., & Brody, J. D. (2022) · Nature Cancer · doi:10.1038/s43018-022-00418-6 · Cited by 843
Turning the corner on therapeutic cancer vaccines
Hollingsworth, R. E., & Jansen, K. (2019) · npj Vaccines · doi:10.1038/s41541-019-0103-y · Cited by 689
Massarelli, E., William, W., Johnson, F., Kies, M., Ferrarotto, R., Guo, M., Feng, L., Lee, J. J., Tran, H., Kim, Y. U., et al. (2019) · JAMA Oncology · doi:10.1001/jamaoncol.2018.4051 · Cited by 490
Metadata
- Authors
- Kim, T. J., Jin, H.-T., Hur, S.-Y., Yang, H. G., Seo, Y. B., Hong, S. R., Lee, C.-W., Kim, S., Woo, J.-W., Park, K. S., Hwang, Y.-Y., Park, J., Lee, I.-H., Lim, K.-T., Lee, K.-H., Jeong, M. S., Surh, C. D., Suh, Y. S., Park, J. S., & Sung, Y. C.
- Venue
- Nature Communications
- Published
- 2014-10-30
- Volume
- 5
- Issue
- 1
- Pages
- 5317-5317
- ISSN
- 2041-1723 (ISSN-L)
- OpenAlex
- W2080731494
- Cited by
- 259
- References
- 55
- FWCI
- 14.38
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.